Xryliderm (Shoreline Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the Xryliderm drug offered from Shoreline Pharmaceuticals, Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shoreline Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | Lidocaine, isopropyl alcohol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-27 |
| END MARKETING DATE: | 0000-00-00 |
Xryliderm HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xryliderm from Shoreline Pharmaceuticals, Inc |
| LABELER NAME: | Shoreline Pharmaceuticals, Inc |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2016-09-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69621-822_2723c988-3bb5-4b43-95a8-941b034e60e3 |
| PRODUCT NDC: | 69621-822 |
| APPLICATION NUMBER: | ANDA200675 |